Sanjay Shrivastava, Ph.D., CEO, "We are extremely pleased with the early clinical performance of the system and look forward to expanding our product launch in the period ahead. Successful use of the System marks an important milestone in our commitment to develop innovative technologies targeting large, underserved markets. We are grateful to our physician advisors, who play a key role in shaping these solutions."